![Bénédicte Menn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bénédicte Menn
Private Equity Investor chez
Oxford University Innovation Ltd.
Profil
Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.
Postes actifs de Bénédicte Menn
| Sociétés | Poste | Début |
|---|---|---|
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Private Equity Investor | 01/01/2017 |
Anciens postes connus de Bénédicte Menn
| Sociétés | Poste | Fin |
|---|---|---|
Neurokin SA
 Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Fondateur | 11/03/2014 |
Formation de Bénédicte Menn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ecole Nationale d'Administration
 Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Finance |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Health Technology |
